Pharmaceutical company AstraZeneca on Monday said that its coronavirus vaccine candidate showed an average efficacy of about 70%. It said that one dose regimen showed vaccine efficacy of 90% when given as half a dose, while another showed 62% efficacy when given as two full doses. The combined analysis from both dosing regimens resulted in an average efficacy of 70%, the company said.
After the announcement, Serum Institute of India Chief Executive Officer Adar Poonawalla said a minimum of 100 million doses of the vaccine will be available by January.
Meanwhile, India’s coronavirus tally rose to 91,39,865 on Monday morning as it reported 44,059 new cases in 24 hours. The toll rose by 511 to 1,33,738. As many as 85,62,641 people have recovered so far.
Globally, the coronavirus has infected more than 5.85 crore people and killed 13,86,596, according to the Johns Hopkins University. More than 3.74 crore people have recovered from the infection.
The national helpline number for the coronavirus is 011-23978046, and a toll-free number is 1075.